April 4 (Reuters) - Johnson & Johnson ( JNJ ) said on
Thursday it has recommended its shareholders to reject an
unsolicited "mini-tender" offer by TRC Capital Investment
Corporation for about 0.04% of its common stock.
The drugmaker said Ontario-based TRC Capital has offered to
purchase up to 1 million shares of J&J's stock at a price of
$151.23 per share in cash.